Change over period: —
NSE · INDIAGLYCO
INDIAGLYCO
-77.4% from the 52-week high · +15.1% above the low
India Glycols Ltd. operates as a holding company, which engages in the manufacture of industrial chemicals such as green technology based bulk, specialty and performance chemicals and natural gums and industrial gases, ethyl alcohol (Potable) and nutraceuticals. The company is headquartered in Noida, Uttar Pradesh and currently employs 1,284 full-time employees. The firm's segments include Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The Bio-based Specialities and Performance Chemicals segment comprises glycols, specialty chemicals, natural gum and other related goods. The Potable Spirits segment is engaged in the manufacturing and sale of ethyl alcohol (potable). The Ennature Biopharma segment is engaged in the manufacturing and sale of nutraceutical products. The company has a product range that covers a variety of specialties and herbal products, such as nutraceuticals, phytochemicals, biopolymers, mainly Polygalactomannans, industrial gases and liquor. The company serves various industries, such as automotive, detergents, healthcare and food processing, mining, and oil and gas, among others.
The short version. INDIAGLYCO reported revenue of ₹362 crore for Sep 2026, down 85.0% from a year earlier. Net profit was ₹24 crore (down 63.1% year on year). Return on equity was 10.0% in Mar 2026. Promoter holding was 59.63% in Sep 2026, down 1.38 points over 8 quarters.
1 · The price
How has the stock traded?
INDIAGLYCO trades 77.4% below its 52-week high and 15.1% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹362 cr.
Sep 2026 net profit of ₹24 cr.
3.8 pts higher than a year earlier.
Revenue compounded at 13.8% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 362 | 2988 | 2360 | 2551 | 2412 | 2503 | 2189 | 2424 |
| Net profit | 24 | 97 | 87 | 68 | 65 | 73 | 64 | 57 |
| Net margin % | 6.5 | 3.2 | 3.7 | 2.6 | 2.7 | 2.9 | 2.9 | 2.3 |
| EPS (₹) | 3.53 | 14.45 | 12.96 | 10.08 | 10.51 | 11.83 | 10.34 | 9.17 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9827 | 9039 | 7922 | 6642 | 6601 | 5427 | 5973 | 5117 |
| Net profit | 293 | 231 | 173 | 125 | 340 | 132 | 115 | 132 |
| Net margin % | 3.0 | 2.6 | 2.2 | 1.9 | 5.1 | 2.4 | 1.9 | 2.6 |
| EPS (₹) | 43.68 | 37.29 | 27.94 | 20.2 | 54.88 | 21.25 | 18.52 | 21.38 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 10.0% in Mar 2026; debt to equity is 0.54.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 10.0 | 10.2 | 8.4 | 6.6 |
| Return on capital % | 11.0 | 10.6 | 10.1 | 8.5 |
| EBITDA margin % | 6.7 | 5.8 | 5.4 | 5.2 |
| Net margin % | 3.0 | 2.5 | 2.2 | 1.9 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 13.8% | 12.6% |
| Profit CAGR | 32.8% | 17.3% |
4 · The owners
Who holds it, and are they adding?
Down 1.38 pts over 8 quarters.
Up 0.32 pts over 8 quarters.
Up 1.05 pts over 8 quarters.
+3 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.01 | 61.01 | 61.01 | 61.01 | 59.63 | 59.63 | 59.63 | 59.63 | -1.38 |
| FII | 2.44 | 2.25 | 3.44 | 2.62 | 2.42 | 2.27 | 2.24 | 2.76 | +0.32 |
| DII | 2.0 | 0.91 | 1.39 | 1.33 | 5.23 | 5.2 | 5.22 | 3.05 | +1.05 |
| Public | 34.54 | 35.83 | 34.16 | 35.03 | 32.72 | 32.9 | 32.91 | 34.55 | +0.01 |
Mutual fund holdings · Oct 2026
6 schemes hold this stock
3 the month before.
- SAMCO MULTI CAP FUND0.29% of NAV
- Motilal Oswal Nifty Microcap 250 Index Fund0.09% of NAV
- Mirae Asset Nifty Total Market Index Fund0.0% of NAV
- Groww Nifty Total Market Index Fund0.0% of NAV
- Angel One Nifty Total Market ETF0.0% of NAV
- Angel One Nifty Total Market Index Fund0.0% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for INDIAGLYCO are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Beverages stocks
Quick answers
Common questions about INDIAGLYCO
What is the INDIAGLYCO share price?
INDIAGLYCO (INDIAGLYCO) last closed at ₹270.00, down 0.64% on the day. Its 52-week range is ₹236.20 to ₹1,203.30.
What is the market cap of INDIAGLYCO?
INDIAGLYCO has a market capitalisation of about ₹1,823 crore. Its price-to-earnings ratio is 5.5.
How are INDIAGLYCO's latest results?
INDIAGLYCO reported revenue of ₹362 crore for Sep 2026, down 85.0% from a year earlier. Net profit was ₹24 crore (down 63.1% year on year). Return on equity was 10.0% in Mar 2026. Promoter holding was 59.63% in Sep 2026, down 1.38 points over 8 quarters.
Who owns INDIAGLYCO?
As of Sep 2026, shareholding was: Promoter 59.63%, FII 2.76%, DII 3.05%, Public 34.55%.
How many mutual funds hold INDIAGLYCO?
6 mutual fund schemes held INDIAGLYCO in October 2026. That compares with 3 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 23 Mar 2026 · Interim Dividend - Rs. 7.5
- 23 Sep 2025 · Final Dividend - Rs. 5
- 12 Aug 2025 · Stock Split From Rs.10/- to Rs.5/-
- 21 Aug 2024 · Final Dividend - Rs. 8
- 05 Sep 2023 · Final Dividend - Rs. 7.5
- 29 Aug 2022 · Final Dividend - Rs. 7.5
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.